Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has named Mansuo Shannon, PhD as the company’s next Chief Scientific Officer (CSO).   Shannon joins AskBio from Prevail Therapeutics, where she also served as CSO. Reporting to Gustavo Pesquin, Chief Executive Officer, Shannon will be a member of AskBio’s Executive Leadership Team and head its R&D organization.   She succeeds Co-Founder R. Jude Samulski, PhD, who served as CSO si...